$143.82
2.63% yesterday
Nasdaq, Nov 25, 10:04 pm CET
ISIN
US4523271090
Symbol
ILMN

Illumina Stock price

$143.82
+1.87 1.32% 1M
+40.08 38.63% 6M
+8.16 6.01% YTD
+51.60 55.96% 1Y
-212.34 59.62% 3Y
-165.26 53.47% 5Y
-40.53 21.98% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+3.68 2.63%
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Key metrics

Market capitalization $22.81b
Enterprise Value $24.54b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 44.95
EV/Sales (TTM) EV/Sales 5.59
P/S ratio (TTM) P/S ratio 5.20
P/B ratio (TTM) P/B ratio 10.69
Revenue growth (TTM) Revenue growth -1.68%
Revenue (TTM) Revenue $4.39b
EBIT (operating result TTM) EBIT $974.00m
Free Cash Flow (TTM) Free Cash Flow $546.00m
Cash position $939.00m
EPS (TTM) EPS $-10.00
P/E forward negative
P/S forward 5.29
EV/Sales forward 5.69
Short interest 4.82%
Show more

Create a Free Account to create an Illumina alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Illumina Stock Analysis

Analyst Opinions

27 Analysts have issued a Illumina forecast:

14x Buy
52%
12x Hold
44%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Illumina forecast:

Buy
52%
Hold
44%
Sell
4%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
4,390 4,390
2% 2%
100%
- Direct Costs 1,582 1,582
8% 8%
36%
2,808 2,808
2% 2%
64%
- Selling and Administrative Expenses 200 200
81% 81%
5%
- Research and Development Expense 1,244 1,244
8% 8%
28%
1,364 1,364
307% 307%
31%
- Depreciation and Amortization 390 390
9% 9%
9%
EBIT (Operating Income) EBIT 974 974
1,147% 1,147%
22%
Net Profit -1,585 -1,585
41% 41%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
Seeking Alpha
6 days ago
Illumina, Inc. (NASDAQ:ILMN ) Wolfe Research 2024 Healthcare Conference Call November 20, 2024 9:20 AM ET Company Participants Ankur Dhingra - Chief Financial Officer Conference Call Participants Doug Schenkel - Wolfe Research Doug Schenkel All right. Good morning, everybody.
Neutral
PRNewsWire
7 days ago
The latest solution to enable comprehensive genomic profiling of tumors will be presented at the  annual meeting of the Association of Molecular Pathology Customer-led research and presentations at the conference will deliver the latest evidence and education in tumor profiling SAN DIEGO , Nov. 19, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-b...
Neutral
PRNewsWire
20 days ago
SAN DIEGO , Nov. 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: Wolfe Research 2024 Healthcare Conference on November 20, 2024 Fireside chat at 6:20am Pacific Time (9:20am Eastern Time) 7th Annual Evercore HealthCONx Conference on December 3, 2024 Fireside chat at 10:20am Pacific Time (1:20pm East...
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 12,010
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today